Bristol-Myers Squibb Co. (NYSE:BMY)

Medicine pills

Short Sellers Increase Bets in Major Pharma

The short interest data have been released for the January 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Short Sellers Become More Selective on Major Pharma

The short interest data have been released for the January 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Takes Another Giant Leap Forward

The short interest data have been released for the December 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Short Interest in Major Pharma Takes a Giant Leap

The short interest data have been released for the November 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: athenahealth, AT&T, Cepheid, Chevron, Dollar General, Mobileye and Many More

Stocks were looking for direction on Wednesday, but that is after a very strong gain on Tuesday. Investors have proven that they will buy stocks on pullbacks for four years ...
Read Full Story »
Prescription drugs

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

Short Sellers Have Mixed Views on Major Pharma

The short interest data have been released for the October 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

Short Sellers Become More Selective on Major Pharma

The short interest data have been released for the September 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
FDA_Sign

5 Big FDA Decisions Expected in October

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to biotech ...
Read Full Story »
Prescription drugs

Short Sellers Boost Positions in Major Pharma

The short interest data have been released for the September 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Pills

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the August 31 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Pills

Short Sellers Have Mixed Feelings on Major Pharma

The short interest data have been released for the August 14 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

4 Top Pharma Stocks That Should Outperform Out To 2016

With a very nervous market, and the end of summer doldrums upon us, it may be time to look for ideas that will make sense when the market heats back ...
Read Full Story »
fda_logo

Why the FDA Extended Review Date on Key Melanoma Drug Opdivo

Bristol-Myers Squibb Co. (NYSE: BMY) was recently featured by 24/7 Wall St. on the calendar of five key upcoming FDA events to watch in the bio-health sector. Now there is ...
Read Full Story »